Pharmaceutical combination for the prophylaxis or treatment of cardiovascular, cardiopulmonary, pulmonary or renal diseases

Details for Australian Patent Application No. 2004204353 (hide)

Owner Boehringer Ingelheim International GmbH

Inventors Sendra, Josep-Maria; Leiter, Josef M. E.; Kauschke, Stefan; Mark, Michael; Riedel, Axel

Agent Davies Collison Cave

Pub. Number AU-A-2004204353

PCT Pub. Number WO2004/062729

Priority 103 01 372.5 16.01.03 DE; 103 35 027.6 31.07.03 DE

Filing date 14 January 2004

Wipo publication date 29 July 2004

International Classifications

A61P 009/10 Drugs for disorders of the cardiovascular system

A61K 031/41 - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

A61K 031/366 - having six-membered rings, e.g. delta-lactones

Event Publications

25 August 2005 PCT application entered the National Phase

  PCT publication WO2004/062729 Priority application(s): WO2004/062729

6 August 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004204355-PDE4 inhibitors for the treatment of neoplasms of lymphoid cells

2004204352-Pharmaceutical combination of telmisartan and atorvastatin for the prophylaxis or treatment of cardiovascular, cardiopulmonary, pulmonary or renal diseases